Fundraising Fox

Inflammatix

Burlingame, US · Founded 2016 · Delaware corporation · 5 known investors

inflammatix.com ↗

Inflammatix develops host-response-based molecular diagnostics tests to identify acute infections and sepsis in emergency and critical care settings. The company's diagnostic platform serves healthcare providers treating acutely ill patients, with applications extending to emerging infectious diseases, autoimmune conditions, and transplant rejection.

AI & Machine LearningBiotechHealthtechMedical Devicesin /inflammatix@inflammatix_inc

Founders & leadership

TSTim Sweeney
Tim SweeneyCo-Founder and CEO
PK
Purvesh KhatriCo-Founder and Chief Scientist
JR
JONATHAN ROMANOWSKYExecutive Officer
KB
KENNETH BAHKDirector
DP
DAVID PERSINGDirector
ST
STEVEN TABLAKDirector
MR
MICHAEL RUBINDirector

Investors · 5

Khosla Ventures✓ verifiedMenlo Park · $5K – $50M
Northpond Ventures✓ verifiedBethesda · $100K – $5M
OSF VenturesPeoria
Think.HealthBerlin · $550K – $11M
DFJreportedSan Mateovia Justin Kao · board

Reported raises · per SEC filings

Form D private placements
▶$102.4MraisedMar 2021 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • MICHAEL RUBINDirector
  • JUSTIN KAODirector
  • KENNETH BAHKDirector
  • TIMOTHY SWEENEYExecutive Officer, Director
  • STEVEN TABLAKDirector
  • DAVID PERSINGDirector
Offering amount
$102.4M
Amount sold
$102.4M
First sale
Mar 2021
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$32.1MraisedFeb 2020 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • TIMOTHY SWEENEYExecutive Officer, Director
  • JONATHAN ROMANOWSKYExecutive Officer
  • KENNETH BAHKDirector
  • DAVID PERSINGDirector
  • STEVEN TABLAKDirector
  • MICHAEL RUBINDirector
Offering amount
$32.1M
Amount sold
$32.1M
First sale
Jan 2020
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news